A Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus Infection of the Lower Respiratory TractFrancisco M. Marty, Sanjeet Dadwal, Anne Bergeron et al.|Clinical Infectious Diseases|2019Cited by 76
A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant RecipientsRoy F. Chemaly, Michael Boeckh, Sanjeet Dadwal et al.|Clinical Infectious Diseases|2019Cited by 75
Azithromycin Use and Increased Cancer Risk among Patients with Bronchiolitis Obliterans after Hematopoietic Cell TransplantationGuang‐Shing Cheng, Anne Bergeron, Louise Bondeelle et al.|Biology of Blood and Marrow Transplantation|2019Cited by 39